Identification of genes required for the survival of B. fragilis using massive parallel sequencing of a saturated transposon mutant library
© Veeranagouda et al.; licensee BioMed Central Ltd. 2014
Received: 5 March 2014
Accepted: 27 May 2014
Published: 4 June 2014
Bacteroides fragilis is a Gram-negative anaerobe that is normally a human gut commensal; it comprises a small percentage of the gut Bacteroides but is the most frequently isolated Bacteroides from human infections. Identification of the essential genes necessary for the survival of B. fragilis provides novel information which can be exploited for the treatment of bacterial infections.
Massive parallel sequencing of saturated transposon mutant libraries (two mutant pools of approximately 50,000 mutants each) was used to determine the essential genes for the growth of B. fragilis 638R on nutrient rich medium. Among the 4326 protein coding genes, 550 genes (12.7%) were found to be essential for the survival of B. fragilis 638R. Of the 550 essential genes, only 367 genes were assigned to a Cluster of Orthologous Genes, and about 290 genes had Kyoto Encyclopedia of Genes and Genomes orthologous members. Interestingly, genes with hypothetical functions accounted for 41.3% of essential genes (227 genes), indicating that the functions of a significant percentage of the genes used by B. fragilis 638R are still unknown. Global transcriptome analysis using RNA-Seq indicated that most of the essential genes (92%) are, in fact, transcribed in B. fragilis 638R including most of those coding for hypothetical proteins. Three hundred fifty of the 550 essential genes of B. fragilis 638R are present in Database of Essential Genes. 10.02 and 31% of those are genes included as essential genes for nine species (including Gram-positive pathogenic bacteria).
The essential gene data described in this investigation provides a valuable resource to study gene function and pathways involved in B. fragilis survival. Thorough examination of the B. fragilis-specific essential genes and genes that are shared between divergent organisms opens new research avenues that will lead to enhanced understanding of survival strategies used by bacteria in different microniches and under different stress situations.
The human gut is home to 10-100 trillion generally symbiotic bacteria that comprise the gut microbiome . Some species become very pathogenic and cause serious infection if they escape their normal niche because of a compromised host gut (due to ulcers, cancer, trauma, surgery or other factors). Bacteroides fragilis is one such example. As a commensal it provides many benefits to the host, including digestion of complex polysaccharides, production of volatile fatty acids, bile acid recycling and immunity development. However, outside its niche B. fragilis can be an opportunistic pathogen [2–5].
While B. fragilis accounts for only a small percentage of the gut Bacteroides, it is the major Bacteroides species isolated from human infections . While the scope of the factors that account for the particular virulence of B. fragilis are not fully known, several virulence factors have been described including the ability to withstand low concentrations of oxygen , release of degradative enzymes such as fibrinogenolysin , enterotoxin production, evasion of complement-mediated killing and phagocytosis, induction of abscess formation, and extensive within-strain variation of surface proteins and polysaccharides (PSs) [8, 9]. The capsular polysaccharides (CPS) that can induce abscess formation  have been extensively studied. Intra-abdominal abscesses can result in intestinal abstraction, erosion of resident blood vessels and ultimately fistula formation. Abscesses may also rupture and result in bacteremia [3, 4].
In many cases, treatment of B. fragilis infection is problematic owing to its high level of resistance to multiple classes of antibiotics. Many B. fragilis clinical isolates are resistant to aminoglycosides, β-lactams and macrolide antibiotics . Resistance to metronidazole, the most widely prescribed antibiotic for B. fragilis infections, is also increasing [2, 11, 12]. Identification of essential genes (i.e., the genes that are indispensable for the survival of an organism under specific conditions) helps in defining targets for new antimicrobial agent development . In addition, essential genes conserved across the species may serve as potential targets for designing broad-spectrum antibiotics. In fact, this approach was used in identifying new antimicrobial targets in Burkholderia thailandensis . On the other hand, if a narrow spectrum was desired, an agent that targeted only functions specific to the pathogen could potentially be designed.
Recent advancement in sequencing technologies has allowed the simultaneous study of large mutant libraries and the subsequent identification of genes necessary for bacterial survival [14, 15] and has resulted in the identification of essential genes in many pathogenic bacteria such as Mycobacterium tuberculosis, Salmonella typhimurium, Helicobacter pylori, and Pseudomonas aeruginosa [16–19]. The results of many of these studies been collated in a Database of Essential Genes (DEG) .
We undertook this study to identify the essential genes of B. fragilis 638R. Essential gene identification has limitations irrespective of method used (either gene deletion or transposon gene disruption) . One of the key factors for success in essential gene identification in bacteria is the generation of mutants. Mutants can be generated either using traditional methods such as gene deletion by homologous recombination or by using a transposon delivery vector. Although the traditional method may be more technically rigorous, it is very labor-intensive and therefore expensive [22, 23] especially in B. fragilis species that is less amenable for genetic manipulation due to its Restriction/Modification system . On the other hand, transposon mutant generation is relatively easy but requires an efficient and unbiased transposon delivery vector. In addition, the advantage of transposon mutagenesis is that it allows the simultaneous study of the large number of mutants in a variety of conditions, thereby identifying the genes important or detrimental to growth in that particular condition. Interestingly, the mariner transposon vector pSAM_Bt, developed for use in B. thetaiotaomicron  was useful for constructing saturated transposon libraries of B. fragilis 638R, a frequently used strain in molecular studies of B. fragilis . In addition, pSAM_Bt has been successfully used for essential gene identification in B. thetaiotaomicron and P. gingivalis [14, 21]. In the present investigation we generated a saturated mutant library using pSAM_Bt and identified the genes required for the survival of B. fragilis.
Results and discussion
Construction of transposon mutant library and mutants’ analysis
We previously described the technique of B. fragilis 638R transposon mutant library construction used in this analysis . The pSAMBt mariner transposon that was designed for essential gene identification has 1) Illumina P7 sequencing adapters (P7) near inverted repeats that facilitate sequencing of mutants and 2) a two-hairpin motif downstream of the ermF cassette that prevents read-through of the transposon disrupted gene . For the subsequent mutant analysis we used the procedure described in detail for the identification of the essential genes in Porphyromonas gingivalis .
We independently generated two ~50,000 mutant libraries (i.e., biological replicates MP1 and MP2). After the genomic DNA preparation, each of these samples was split into two technical replicates (TR) to minimize any changes due to technical variation introduced by downstream manipulations (i.e., shearing of mutant DNA, transposon junction recovery by C-tailing followed by PCR and NGS sequencing). These samples (MP1-TR1, MP1-TR2, MP2-TR1 and MP2-TR2) were used for the identification of transposon disrupted region as described .
Identification of candidate essential genes
B. fragilis 638R has 4326 protein coding genes, 72 tRNA genes and 19 rRNA genes . We investigated the genes that were disrupted by transposons in two independent mutant pools. Genes that had transposon insertions in the last 5% of the gene (3' end) were filtered out since they may likely to generate active product and the remaining reads were mapped against the B. fragilis 638R genome . Analysis of the mutant pool indicated that 3763 of the 4326 genes, 55 of the 72 tRNA genes and all nineteen rRNA genes were disrupted by the transposon. Of the 3763 disrupted genes, 201 were disrupted only once in either one or both the biological replicates. Closer examination of these 201 mutant reads indicated that transposon was integrated well within the genes. In addition, all 201 genes were disrupted in a mutant pool which was sequenced following re-growth of mutants on BHI medium, confirming that these genes are not essential for survival of B. fragilis 638R. There were 1764 genes with 1-5 disruptions and 1798 genes with 6-198 disruptions in both biological replicates. Thus, 3762 genes (~87%) can be individually disrupted without eliminating growth of B. fragilis 638R on BHI medium.
COG and KEGG classification of essential genes
Four of the six subunits of DNA polymerase III holoenzyme (dnaE, BF638R_2865, BF638R_2439, BF638R_3948), DNA elongation and topology changing genes (ligA, gyrA, gyrB and parE), and a few, but not all, recombination repair genes (ruvB, uvrD, ruvX, refC, and polA) were essential. In the transcription pathway, the core subunit of RNA polymerase (rpoA), transcription terminator (rho), antitermination protein (nusG), nitrogen utilization regulator (nusA and nusB) and several other sigma factors were essential. The translation, ribosomal structure and biogenesis COG group included many essential genes encoding 30S and 50S ribosomal proteins (BF638R_4015-BF638R_4045, and BF638R_4053- BF638R_4059) and all twenty aminoacyl tRNA synthetase genes were identified as essential genes. In addition, a few, but not all, genes involved in translation initiation (infA, B and C), elongation (tsf, fusA and tuf) and release factors (frr, prfA and pth) were essential.
The 41 essential genes in the cell wall/membrane/envelope biogenesis pathway code for proteins involved in peptidoglycan biosynthesis, LPS core region and lipid-A biosynthesis; proteins for O-antigen biosynthesis were not among the essential genes. In the signal transduction pathway, one two-component regulator was essential (rprX/rprY). The genes encoding for chaperones (heat shock protein) such as groEL, groES, grpE and ftsH (BF638R_0745) were also identified as essential for B. fragilis growth. Also, many genes involved in amino acid, nucleotide, lipid and cofactor metabolism were present in the essential gene list.
Conjugation associated tragenes
Surprisingly, many conjugation related genes (such as traB, traE, traF, traH, traF, traI, traQ) were classified as essential genes. Similar conjugation transfer related genes were also present in the essential gene list of B. thetaiotaomicron  and particular domains of certain of the tra genes were not disrupted in P. gingivalis, although the other domains were disrupted . The function of these genes outside of their importance in conjugation has not been described. The results suggest that they either have some function in cell viability or are somehow not available for transposon insertion.
Capsular polysaccharides (CPS) biosynthesis, RND efflux pumps and many regulator genes are not essential genes
Interestingly the genes in the eight clusters involved in CPS biosynthesis, the sixteen RND efflux pump genes and the 32 araC-type regulator genes are not among the essential genes of B. fragilis 638R, although a few of them have been shown to be critical in B. fragilis under specific conditions. Since these gene classes are particularly redundant in B. fragilis, it is reasonable to presume that the deleted gene is complemented by homologous members. It would be tempting to speculate that the essential genes are more likely to be non-redundant with a critical function that is not complemented by homologous genes. It is of special interest that the two component transduction regulator, rprX, is essential in spite of having seventeen and thirty-six homologs respectively in the Database of Essential Genes (DEG) for rprX and rprY, respectively. The B. fragilis rprX/rprY genes expressed from a multicopy plasmid in E. coli affect the respective levels of the OmpF and OmpC porins, perhaps by interfering with normal regulation of OmpF  and in P. gingivalis, RprY appears to regulate stress responses .
Essential genes of unknown function
Only 367 (66.7%) of the essential genes could be assigned to a COG functional category (Additional file 1: Table S1) and 44 of these genes had no specific function delineated. The remaining 183 (33.3%) essential genes that were not assigned to COG groups coded for hypothetical proteins. Thus, 227 (44 + 183) genes (41.3%) of the essential genes encode hypothetical proteins, demonstrating that the functions for nearly half of the genes critical for B. fragilis survival are still unknown.
Comparison of B. fragilis638R essential genes with related strains
Comparison of B. fragilis 638R essential genes with B. thetaiotaomicron VPI-5482 and P. gingivalisATCC 33277
Genes needed in one bacterium are not necessarily essential in another species and comparing the essential genes of divergent species can provide valuable information about networks that are shared or not shared between organisms. We looked for homologs of B. fragilis essential genes in the related species B. thetaiotaomicron VPI-5482 (BT) and in the periodontal pathogen P. gingivalis ATCC 33277 (PG). The essential genes in BT and PG were previously identified using a saturated transposon mutant library [14, 21] and have 325 and 463 essential genes, respectively. Therefore, we also determined which of the essential genes of BF638R were also essential in those two species. Since BT and PG are less closely related to B. fragilis 638R, relatively fewer genes are conserved across the whole genome; sixty-nine percent (2986/4326) and 35% (1527/4326) of B. fragilis 638R genes are conserved in BT and PG respectively. Interestingly, 77% (425/550) and 64.6% (355/550) of the essential genes of B. fragilis 638R have close homologs in BT and PG, respectively (Figure 4, Additional file 2: Table S2) but not all of them are designated as essential in the other species. In fact, only 200 and 279 of the B. fragilis 638R essential genes are shared as essential genes by BT and PG, respectively (Additional file 2: Table S2). The majority of the conserved genes are highly enriched in certain COG groups (Additional file 2: Table S2). Many B. fragilis 638R essential genes (174, 47.41%) assigned to COG groups with critical functions (including chaperones (grpE, groES), recombination and repair (polA, ruvB, ruvX, uvrD), N-utilization regulator (BF638R_1213), thiamine biosynthesis (BF638R_2546, BF638R_2547) and many transcriptional regulators (BF638R_0733, BF638R_1336, BF638R_1533, BF638R_2028, BF638R_2310, BF638R_2798, BF638R_2903 and BF638R_3831) are, in fact, not essential for B. thetaiotaomicron VPI-5482.
Although B. fragilis and P. gingivalis live in widely different niches (gut and oral cavity), more B. fragilis essential genes are present in the oral anaerobe P. gingivalis ATCC 33277 essential genes than in the gut anaerobe B. thetaiotaomicron VPI-5482. The reasons for this are not clear. Essential genes with known function that are shared between B. fragilis 638R and P. gingivalis but not essential for B. thetaiotaomicron include 1) thirty-four genes belongs to translation, ribosomal structure and biogenesis, 2) eight genes involved in cell wall/membrane/envelope biogenesis, and 3) chaperones (BF638R_3251). In addition, all six genes involved in lipid-A biosynthesis are essential for B. fragilis 638R and P. gingivalis ATCC 33277 (lpxA, lpxC, lpxD, BF638R_0493, lpxB, and BF638R_3307), however only the latter three genes are essential in B. thetaiotaomicron VPI-5482 even though all of the six genes are present only in a single copy in the B. thetaiotaomicron VPI-5482 genome . Thus, although B. fragilis 638R and B. thetaiotaomicron VPI-5482 are closely related species, they apparently rely on different sets of essential genes for their survival. Presumably, B. thetaiotaomicron has other homologs that code for these essential functions that were not picked up in the BLAST analysis for essential genes. About 21% (115) of the B. fragilis 638R essential genes which are missing in B. thetaiotaomicron and P. gingivalis are annotated as hypothetical proteins (Additional file 2: Table S2). Further study of the species and strain specific requirements of B. fragilis strains will help us to understand its abilities to adapt to specific microniches.
Comparison of B. fragilis638R essential genes with the database of essential genes (DEG)
Comparison of essential genes of Bacteroides fragilis 638R to other species in the DEG
No. essential genes
Number of homologs of B. fragilis 638R essential genes present in other bacteria
% of B. fragilis 638R essential genes present in other bacteria
B. fragilis 638R
P. gingivalis ATCC 33277
B. thetaiotaomicron VPI-5482
Mycobacterium tuberculosis H37Rv II
Salmonella enterica serovar Typhi
Staphylococcus aureus NCTC 8325
Burkholderia thailandensis E264
Bacillus subtilis 168
E.coli MG1655 II
Most of the genes that had no homologs in the DEG (175/200) coded for a hypothetical protein. (This is expected because the annotation server depends on characterized homologs to assign homologs). The annotated protein sequences of these genes were also submitted to the Phyre2 server that predicts function based on conserved fold analysis; in some cases the Phyre2 server will predict function when the other servers do not. Phyre 2 analysis predicted functions for 4 genes which were previously annotated only as hypothetical proteins: BF638R_0208 and BF638R_0260 (PG016-like [2 helical bundles]), BF638R_2531 (hth-type transcriptional regulator) and BF638R_4199 (thioredoxin like) (Additional file 1: Table S1).
Transposon insertion in certain genes may not be tolerated, not because those genes themselves are essential, but because the disruptions may affect expression of downstream essential genes present within the same operon. Therefore, we analyzed potential polar effects of the B. fragilis 638R essential genes. Based on the operon prediction, disruptions in 74 of the 550 essential genes are likely to have a polar effect on downstream genes present in the same operon (Additional file 1: Table S1). These 74 genes are at the upstream end of an operon that contains one or more known essential genes as described in the DEG. Interestingly, 55 of those 74 genes are also present in the DEG; many of those genes are conserved in essential genes of more than one strain and deserve further study.
Transcription analysis of essential genes
Whole genome transcription analysis by RNA-seq  indicated that 4093 of 4326 (94.6%) genes are transcribed in B. fragilis 638R. Transcription levels of essential genes demonstrated that most of the essential genes with assigned COG (320 of the 323) are transcribed (ribosomal genes, for example, are highly transcribed) (Additional file 1: Table S1). Also, 187/227 genes classified as hypothetical proteins are transcribed. Mid-log cells were used for RNASeq analysis, thus it is possible that the other 40 genes which did not show transcript/expression may be transcribed at a different growth stage. This data suggests that many genes with completely unknown function are essential for the growth of B. fragilis 638R.
We identified the essential genes required for the survival of B. fragilis 638R in BHI medium using a transposon delivery vector and Illumina sequencing technology. The results indicate that only 12.7% (550) genes are essential. The B. fragilis genome is known for having redundant genes; for example, it has sixteen RND efflux pumps, at least four genes for the major membrane protein OmpA , more than 32 araC-type regulators , multiple operons for the degradation of dietary polysaccharides, and eight operons for capsular polysaccharides. In cases of gene redundancy, a disrupted gene may be complemented by another gene (presumably a homolog), and it would be expected that genes with multiple homologs might not be essential for survival of B. fragilis 638R but will result in synthetic lethality if all homologs are targeted. Thus, most of the essential genes described for B. fragilis 638R are genes which do not have a complementary gene. Further study is needed to determine why specific genes are essential, particularly for the 227 genes code for hypothetical proteins with no known function. Since most of the essential genes code for proteins that are involved in fundamental biological process such as translation, cell wall biogenesis, translation and transcription, we presume that 277 hypothetical genes also encode for proteins in vital pathways. Further characterization of these hypothetical proteins may provide novel information about unique pathways used by B. fragilis.
Strains and culture conditions
The B. fragilis 638R used in this study was originally isolated from an abdominal abscess . B. fragilis and E. coli were grown in brain heart infusion (BHI) and LB broths, respectively, at 37°C. E. coli Top10 (Invitrogen, NY, USA) and E. coli S-17-1 λ pir strains were used as the host for cloning. E. coli S17-1 λ pir contains the pir gene and has chromosomally integrated conjugational transfer functions (RP4/RK6) so that bi-parental mating can take place in lieu of tri-parental mating using helper strains.
Transposon mutagenesis and mutant library construction
B. fragilis was mutagenized using the mariner transposon vector as described previously . Fifteen independent mating mixes (1 ml each) were pooled (15 ml) and stored as 1 ml aliquots at -80°C. Frozen aliquots were thawed and plated on BHI/gentamycin (25 μg/ml)/erythromycin (10 μg/ml)/rifampin (10 μg/ml) plate and incubated at 37°C for 3 days. The two mutants pools were generated by scraping the growth (approximately 50,000 mutant colonies) from the plate and suspending in 15 ml of LB/glycerol (20% v/v) medium. The resultant fifty thousand mutant pools were stored as 1 ml aliquots at -80°C.
Sequencing mutants and mapping mutated genes
Four tubes of stored glycerol stocks of the mutant pool were used to make genomic DNA. The genomic DNA was prepared using ZR Fungal/Bacterial DNA MidiPrep™ kit (Zymo Research Corporation, CA). The technical replicates for each mutant pool were prepared by splitting genomic DNA into two. The transposon mutants in the mutant pool were identified essentially as described by Klein et al. .
DNA shearing and adding C-tail
The genomic DNA from the mutants (10 μg) was sheared to 300 to 500 bp at the Biomedical Genomics Core Facility (San Diego) using the Covaris E220 focused ultrasonicator. C-tails were added to the sheared DNA using the terminal transferase kit (New England Biolabs, MA) and the chain terminator ddCTP (GE Healthcare Biosciences, NJ). C-tailing was carried out in a 60 μl reaction mixture (6 μl of 10X buffer, 6 μl of 2.5 mM CoCl2, 3 μl of dCTP (9.5 mM) –ddCTP (0.5 mM) mix, 3 μg of sheared DNA and 3 μl terminal transferase (20 units/μl) with the appropriate volume of water. The reaction mix was incubated at 37°C for 60 minutes and heat inactivated by incubating at 70°C for 10 minutes. The reaction mixture was purified using DNA Clean & Concentrator™ (Zymo Research Corporation, CA) and eluted with 15 μl elution buffer.
Transposon junction amplification, adding Illumina adaptors and indexing sites
Sheared/C-tailed DNA was amplified with primers that would amplify fragments containing the transposon IRR (inverted repeat right) along with the mutant junction DNA; the amplification was carried out in a 150 μl reaction mixture containing 15 μl C-tailed DNA as template, 75 μl Phusion® High-Fidelity PCR Master Mix (New England Biolabs, MA), 3 μl of 30 μM- olj376 (5' GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGGGGGGGGGGGGGGGG 3'), 3 μl 30 μM- pSAM1 (5' CCTGACGGATGGCCTTTTTGCGTTTCTACC 3') primers and the appropriate volume of water. The 150 μl reaction mixture were split into 3 tubes (50 μl each) and the PCR conditions were: 2 min at 95°C, 24 cycles of 10 s at 95°C, 30 s at 60°C, and 60 s at 72°C followed by a final extension for 1 min at 72°C. All three reactions were pooled and used as template to add Illumina sequencing and indexing sites. The second PCR consisted of 4 μl of first PCR product as template, 100 μl Phusion® High-Fidelity PCR Master Mix, 88 μl water, 4 μl of 30 μM pSAM2 (5' AATGATACGGCGACCACCGAGATCTACACTCTTTGACCGGGGACTTATCATCCAACCTGTTA 3') and 4 μl of 30 μM indexing primer (5' CAAGCAGAAGACGGCATACGAGATNNNNNNGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 3'). The 200 μl reaction mixture was split into 4 tubes (50 μl each); PCR conditions were 2 min at 95°C, fourteen cycles of 10 s at 95°C, 30 s at 52°C, and 120 s at 72°C followed by a final extension for 5 min at 72°C. The samples were then pooled and purified using the QIAquick PCR Purification Kit (QIAGEN, Valencia, CA) and eluted with 30 μl elution buffer.
Sequencing mutant junctions and mapping to the genome
The amplified DNA fragments were sequenced on a single end Illumina flow cell using the Genome Analyzer II (TUCF Genomics, MA), for 51 cycles with custom primer which binds to IRR (pSAM3 -5' ACACTCTTTGACCGGGGACTTATCATCCAACCTGTTA 3') of the transposon DNA and the standard Illumina index sequencing primer. Generated FASTQ files were analyzed essentially as described  at Tufts University Galaxy server (http://galaxy.med.tufts.edu/) using B. fragilis 638R as the reference genome. Mapped reads are normalized as number of unique insertions per gene and compared between mutant libraries.
Mid-log cells of B. fragilis grown on BHI broth were harvested and RNA was prepared using the RNeasy minikit with RNAprotect bacterial reagent (QIAGEN, Valencia, CA). Purified total RNA was again treated with RNase-free DNase kit (QIAGEN, Valencia, CA). Following RNase-free DNase treatment, reduction in genomic DNA in the RNA sample was confirmed by qRTPCR; RNase-free DNase treatment effectively reduced genomic DNA contamination by >1000 fold. The majority of the rRNA (>95%) was removed from total RNA using the MICROBExpress™ Bacterial mRNA Enrichment Kit (Life Technologies Corporation) leaving enriched RNA. The cDNA was prepared from enriched mRNA using the SuperScript® Double-Stranded cDNA Synthesis Kit (Invitrogen™) and subjected to RNA-Seq at Otogenetics (Norcross, USA). The RNA-Seq files were analyzed using the Lasergene Genomics Suite (DNASTAR, Inc, Madison, USA).
The GenBank files (.gbk) of specific bacteria were downloaded from the National Center for Biotechnology Information ftp server. (ftp://ftp.ncbi.nih.gov/genomes/Bacteria/). The cluster of orthologous genes (COG) classification of B. fragilis as well as genome comparisons were from the Integrated Microbial Genomes (IMG) database (https://img.jgi.doe.gov/cgi-bin/w/main.cgi) . The circular maps were constructed using the BLAST Ring Image Generator (BRIG0.95) (http://sourceforge.net/projects/brig/)  or the CGView Server (http://stothard.afns.ualberta.ca/cgview_server/). The formats of sequence file were converted as needed for subsequent analysis at http://sequenceconversion.bugaco.com/converter/biology/sequences/. B. fragilis essential genes were compared with the essential genes of other bacteria at the Database of Essential Genes (DEG).10.02 (http://tubic.tju.edu.cn/deg/) . The distribution of B. fragilis essential genes in various pathways was investigated using the Omics Viewer with B. fragilis 638R as reference genome at http://biocyc.org/overviewsWeb/celOv.shtml and the Kyoto Encyclopedia of Genes and Genomes (KEGG). The KEGG entry number for B. fragilis 638R is T01691. The KEGG orthologous genes and KEGG pathways for B. fragilis 638R essential genes were obtained from the KEGG database (http://www.genome.jp/dbget-bin/www_bget?gn:T01691). We also used PHYRE2 analysis to predict protein function based on fold recognition patterns .
This research is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development and in part by the NIAID (NIH) Grant Number 1R56AI083649-01A2 and T32 5T32AI007389-20.
- Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI: The human microbiome project. Nature. 2007, 449: 804-810. 10.1038/nature06244.PubMed CentralPubMedView ArticleGoogle Scholar
- Wareham DW, Wilks M, Ahmed D, Brazier JS, Millar M: Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy. Clin Inf Dis. 2005, 40: e67-e68. 10.1086/428623.View ArticleGoogle Scholar
- Brook I: The role of anaerobic bacteria in bacteremia. Anaerobe. 2010, 16: 183-189. 10.1016/j.anaerobe.2009.12.001.PubMedView ArticleGoogle Scholar
- Wexler HM: Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev. 2007, 20: 593-621. 10.1128/CMR.00008-07.PubMed CentralPubMedView ArticleGoogle Scholar
- Troy EB, Kasper DL: Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Frontiers bioscience (Landmark edition). 2010, 15: 25-34. 10.2741/3603.View ArticleGoogle Scholar
- Baughn AD, Malamy MH: The strict anaerobe Bacteroides fragilis grows in and benefits from nanomolar concentrations of oxygen. Nature. 2004, 427: 441-444. 10.1038/nature02285.PubMedView ArticleGoogle Scholar
- Houston S, Blakely G, McDowell A, Martin L, Patrick S: Binding and degradation of fibrinogen by Bacteroides fragilis and characterization of a 54 kDa fibrinogen-binding protein. Microbiol. 2010, 156: 2516-2526. 10.1099/mic.0.038588-0.View ArticleGoogle Scholar
- Connolly JC, McLean C, Tabaqchali S: The effect of capsular polysaccharide and lipopolysaccharide of Bacteroides fragilis on polymorph function and serum killing. J Med Microbiol. 1984, 17: 259-271. 10.1099/00222615-17-3-259.PubMedView ArticleGoogle Scholar
- Patrick S, Blakely GW, Houston S, Moore J, Abratt VR, Bertalan M, Cerdeño-Tárraga AM, Quail MA, Corton N, Corton C, Bignell A, Barron A, Clark L, Bentley SD, Parkhill J: Twenty-eight divergent polysaccharide loci specifying within- and amongst-strain capsule diversity in three strains of Bacteroides fragilis. Microbiol. 2010, 156: 3255-3269. 10.1099/mic.0.042978-0.View ArticleGoogle Scholar
- Coyne MJ, Tzianabos AO, Mallory BC, Carey VJ, Kasper DL, Comstock LE: Polysaccharide Biosynthesis Locus Required for Virulence of Bacteroides fragilis Polysaccharide Biosynthesis Locus Required for Virulence of Bacteroides fragilis. Infect Immun. 2001, 69: 4342-4350. 10.1128/IAI.69.7.4342-4350.2001.PubMed CentralPubMedView ArticleGoogle Scholar
- Sherwood JE, Fraser S, Citron DM, Wexler H, Blakely G, Jobling K, Patrick S: Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan. Anaerobe. 2011, 17: 152-155. 10.1016/j.anaerobe.2011.02.007.PubMedView ArticleGoogle Scholar
- Husain F, Veeranagouda Y, Hsi J, Meggersee R, Abratt V, Wexler HM: Two multidrug-resistant clinical isolates of Bacteroides fragilis carry a novel metronidazole resistance nim gene (nimJ). Antimicrob Agents Chemother. 2013, 57: 3767-3774. 10.1128/AAC.00386-13.PubMed CentralPubMedView ArticleGoogle Scholar
- Baugh L, Gallagher L, Patrapuvich R, Clifton MC, Gardberg AS, Edwards TE, Armour B, Begley DW, Dieterich SH, Dranow DM, Abendroth J, Fairman JW, Fox D, Staker BL, Phan I, Gillespie A, Choi R, Nakazawa-Hewitt S, Nguyen MT, Napuli A, Barrett L, Buchko GW, Stacy R, Myler PJ, Stewart LJ, Manoil C, Van Voorhis WC: Combining functional and structural genomics to sample the essential Burkholderia structome. PLoS One. 2013, 8: e53851-10.1371/journal.pone.0053851.PubMed CentralPubMedView ArticleGoogle Scholar
- Goodman AL, Wu M, Gordon JI: Identifying microbial fitness determinants by insertion sequencing using genome-wide transposon mutant libraries. Nat Protoc. 2011, 6: 1969-1980. 10.1038/nprot.2011.417.PubMed CentralPubMedView ArticleGoogle Scholar
- Loman NJ, Constantinidou C, Chan JZM, Halachev M, Sergeant M, Penn CW, Robinson ER, Pallen MJ: High-throughput bacterial genome sequencing: an embarrassment of choice, a world of opportunity. Nat Rev Microbiol. 2012, 10: 599-606. 10.1038/nrmicro2850.PubMedView ArticleGoogle Scholar
- Griffin JE, Gawronski JD, Dejesus MA, Ioerger TR, Akerley BJ, Sassetti CM: High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog. 2011, 7: e1002251-10.1371/journal.ppat.1002251.PubMed CentralPubMedView ArticleGoogle Scholar
- Khatiwara A, Jiang T, Sung SS, Dawoud T, Kim JN, Bhattacharya D, Kim HB, Ricke SC, Kwon YM: Genome scanning for conditionally essential genes in Salmonella enterica Serotype Typhimurium. Appl Environ Microbiol. 2012, 78: 3098-3107. 10.1128/AEM.06865-11.PubMed CentralPubMedView ArticleGoogle Scholar
- Salama NR, Shepherd B, Falkow S: Global Transposon Mutagenesis and Essential Gene Analysis of Helicobacter pylori. J Bacteriol. 2004, 186: 7926-7935. 10.1128/JB.186.23.7926-7935.2004.PubMed CentralPubMedView ArticleGoogle Scholar
- Liberati NT, Urbach JM, Miyata S, Lee DG, Drenkard E, Wu G, Villanueva J, Wei T, Ausubel FM: An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci U S A. 2006, 103: 2833-2838. 10.1073/pnas.0511100103.PubMed CentralPubMedView ArticleGoogle Scholar
- Luo H, Lin Y, Gao F, Zhang CT, Zhang R: DEG 10, an update of the database of essential genes that includes both protein-coding genes and noncoding genomic elements. Nucleic Acids Res. 2013, 42: D574-D580.PubMed CentralPubMedView ArticleGoogle Scholar
- Klein B, Tenorio EL, Lazinski DW, Camilli A, Duncan MJ, Hu LT: Identification of essential genes of the periodontal pathogen Porphyromonas gingivalis. BMC Genomics. 2012, 13: 578-10.1186/1471-2164-13-578.PubMed CentralPubMedView ArticleGoogle Scholar
- Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko K, Tomita M, Wanner BL, Mori H: Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2006, 2: 1-11.View ArticleGoogle Scholar
- Kobayashi K, Ehrlich SD, Albertini A, Amati G, Andersen KK, Arnaud M, Asai K, Ashikaga S, Aymerich S, Bessieres P, Boland F, Brignell SC, Bron S, Bunai K, Chapuis J, Christiansen LC, Danchin A, Débarbouille M, Dervyn E, Deuerling E, Devine K, Devine SK, Dreesen O, Errington J, Fillinger S, Foster SJ, Fujita Y, Galizzi A, Gardan R, Eschevins C, et al: Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A. 200, 100: 4678-4683.View ArticleGoogle Scholar
- Cerdeno Tarraga AM, Patrick S, Crossman LC, Blakely G, Abratt V, Lennard N, Poxton I, Duerden B, Harris B, Quail MA, Barron A, Clark L, Corton C, Doggett J, Holden MT, Larke N, Line A, Lord A, Norbertczak H, Ormond D, Price C, Rabbinowitsch E, Woodward J, Barrell B, Parkhill J: Extensive DNA inversions in the B. fragilis genome control variable gene expression: Supplemental online material. Science. 2005, 307: 1463-1465. 10.1126/science.1107008.PubMedView ArticleGoogle Scholar
- Veeranagouda Y, Husain F, Wexler H: Transposon mutagenesis of Bacteroides fragilis using a mariner transposon vector. Anaerobe. 2013, 22: 126-129.PubMed CentralPubMedView ArticleGoogle Scholar
- Rasmussen BA, Kovacs E: Cloning and identification of a two-component signal-transducing regulatory system from Bacteroides fragilis. Mol Microbiol. 1993, 7: 765-776. 10.1111/j.1365-2958.1993.tb01167.x.PubMedView ArticleGoogle Scholar
- Krishnan K, Duncan M: Role of sodium in the RprY-dependent stress response in Porphyromonas gingivalis. PLoS One. 2013, 8: e63180-10.1371/journal.pone.0063180.PubMed CentralPubMedView ArticleGoogle Scholar
- Kuwahara T, Yamashita A, Hirakawa H, Nakayama H, Toh H, Okada N, Kuhara S, Hattori M, Hayashi T, Ohnishi Y: Genomic analysis of Bacteroides fragilis reveals extensive DNA inversions regulating cell surface adaptation. Proc Natl Acad Sci U S A. 2004, 101: 14919-14924. 10.1073/pnas.0404172101.PubMed CentralPubMedView ArticleGoogle Scholar
- Chaudhuri R, Allen A, Owen P, Shalom G, Stone K, Harrison M, Burgis T, Lockyer M, Garcia-Lara J, Foster S, Pleasance S, Peters S, Maskell D, Charles I: Comprehensive identification of essential Staphylococcus aureus genes using Transposon-Mediated Differential Hybridisation (TMDH). BMC Genomics. 2009, 10: 291-10.1186/1471-2164-10-291.PubMed CentralPubMedView ArticleGoogle Scholar
- Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y: RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res. 2008, 18: 1509-1517. 10.1101/gr.079558.108.PubMed CentralPubMedView ArticleGoogle Scholar
- Wexler H, Tenorio E, Pumbwe L: Characteristics of Bacteroides fragilis lacking the major outer membrane protein, OmpA. Microbiol. 2009, 155: 2694-2706. 10.1099/mic.0.025858-0.View ArticleGoogle Scholar
- Wexler H: Pump it up: occurrence and regulation of multi-drug efflux pumps in Bacteroides fragilis. Anaerobe. 2012, 18: 200-208. 10.1016/j.anaerobe.2011.12.017.PubMedView ArticleGoogle Scholar
- Markowitz VM, Chen IM, Palaniappan K, Chu K, Szeto E, Grechkin Y, Ratner A, Jacob B, Huang J, Williams P, Huntemann M, Anderson I, Mavromatis K, Ivanova NN, Kyrpides NC: IMG: the Integrated Microbial Genomes database and comparative analysis system. Nucleic Acids Res. 2012, 40: D115-D122. 10.1093/nar/gkr1044.PubMed CentralPubMedView ArticleGoogle Scholar
- Alikhan NF, Petty N, Ben Zakour N, Beatson S: BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics. 2011, 12: 402-10.1186/1471-2164-12-402.PubMed CentralPubMedView ArticleGoogle Scholar
- Kelley LA, Sternberg MJ: Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc. 2009, 4: 363-371. 10.1038/nprot.2009.2.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.